Vital Food Processors has launched a transtasman clinical trial of a kiwifruit extract treatment for patients diagnosed with irritable bowel syndrome (IBS).
The 10-centre trial will investigate the efficacy of Kivia, which Vital Foods already markets under the brand name Phloe in the New
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Nevil Gibson for NBR Food Industry Week
Thu, 08 May 2014
Thu, 08 May 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Kiwifruit extract to be tested in clinical trials
37866